Sutro Biopharma Inc. (STRO)
Sutro Biopharma Max Pain By Strike
STRO trades at $0.92, 54.0% below the near-term max pain of $2 expiring Sep 19, 2025 (31 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is rising across expirations ($0.5-$2), reflecting growing call interest at higher strikes. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Sutro Biopharma Max Pain By Expiry
Max pain for STRO shows an upward trend from 0.5 to 2, suggesting bullish positioning in longer-dated options. The 150% spread signals divergent expectations across timeframes. Levels distributed around 0.92. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 2 | 1.08 (116.47%) |
| Oct 17, 2025 | 0.5 | -0.42 (-45.88%) |
| Nov 21, 2025 | 1 | 0.08 (8.24%) |
| Feb 20, 2026 | 0.5 | -0.42 (-45.88%) |